Is an Elevated 17-OHP Level Diagnostic for CAH?
An elevated 17-OHP level alone is not definitively diagnostic for congenital adrenal hyperplasia and requires confirmatory testing with either a cosyntropin stimulation test or genetic analysis to establish the diagnosis. 1
Diagnostic Approach Based on Baseline 17-OHP Levels
The Endocrine Society provides clear thresholds for interpreting baseline early morning serum 17-OHP levels 1:
- >300 nmol/L (>10,000 ng/dL): Likely classic CAH
- 6-300 nmol/L (200-10,000 ng/dL): Likely nonclassic CAH
- <6 nmol/L (<200 ng/dL): Likely unaffected or possible NCCAH
However, these baseline values are only suggestive, not diagnostic. The Endocrine Society explicitly recommends obtaining a complete adrenocortical profile after cosyntropin stimulation testing to differentiate 21-hydroxylase deficiency from other enzyme defects and to make the diagnosis in borderline cases. 1
Why Baseline 17-OHP Can Be Misleading
False Positives Occur Frequently
Elevated 17-OHP does not automatically confirm CAH due to multiple confounding factors 2, 3:
- Premature infants have physiologically elevated 17-OHP levels 1, 3
- Stressed or sick newborns show transient elevations 3
- Immunoassay cross-reactivity produces false elevations 1
- Other enzyme deficiencies (11β-hydroxylase deficiency, P450 oxidoreductase deficiency) also elevate 17-OHP 1
- Adrenal adenomas can secrete 17-OHP, mimicking CAH 4
- Heterozygous carriers may have slightly elevated levels after ACTH stimulation with overlap to unaffected subjects 1
One study found that among women with basal or post-stimulation 17-OHP ≥30 nmol/L, only 24% actually had confirmed NCCAH when urinary steroid profiling and genetic testing were performed. 2
Confirmatory Testing Algorithm
Post-ACTH Stimulation 17-OHP Thresholds
After cosyntropin stimulation, the diagnostic thresholds are 1:
- >300 nmol/L (>10,000 ng/dL): Classic CAH
- 31-300 nmol/L (1,000-10,000 ng/dL): Likely NCCAH
- <50 nmol/L (<1,666 ng/dL): Unaffected or heterozygote
For NCCAH specifically, the traditional cutoff of post-stimulation 17-OHP >1000 ng/dL (33 nmol/L) has been used, though recent LC-MS/MS data suggests lower thresholds may be more accurate. 1, 5
Modern LC-MS/MS Cutoffs Are Lower
Recent research using liquid chromatography-tandem mass spectrometry (LC-MS/MS) demonstrates that immunoassay-based cutoffs overestimate the diagnosis 5:
- Optimal basal 17-OHP cutoff: 0.94 ng/mL (2.82 nmol/L) with 100% sensitivity and 90% specificity for NC-CAH 5
- Optimal peak 17-OHP cutoff: 7.81 ng/mL (23.43 nmol/L) with 100% sensitivity and 97% specificity for NC-CAH 5
These LC-MS/MS thresholds are significantly lower than traditional immunoassay cutoffs, reducing false positives. 5
When to Use Genetic Testing
Genotyping should be reserved for specific situations 1:
- When adrenocortical profile results after cosyntropin stimulation are equivocal 1
- For genetic counseling purposes 1
- When urinary steroid profiling suggests CAH but hormonal results are borderline 2
Important caveat: Genetic testing cannot differentiate salt-wasting from simple virilizing forms—this requires clinical evaluation of electrolytes and plasma renin activity. 1
Critical Pitfalls to Avoid
Do Not Diagnose Based on Immunoassay Alone
Immunoassays lack specificity for 17-OHP due to cross-reactivity with other steroids. 1 The positive predictive value of CAH screening improved from 0.8% to 7.6% when LC-MS/MS replaced immunoassay in Minnesota's newborn screening program. 1
Consider Alternative Diagnoses
Before confirming CAH, exclude 1:
- 11β-hydroxylase deficiency (also elevates 17-OHP)
- P450 oxidoreductase deficiency (also elevates 17-OHP)
- Adrenal or ovarian tumors secreting steroid precursors 4
Measuring a complete steroid panel including 21-deoxycortisol, androstenedione, testosterone, deoxycorticosterone, and 11-deoxycortisol helps differentiate these conditions. 1
Timing Matters for Baseline Samples
Obtain baseline 17-OHP in early morning during the follicular phase in women to minimize physiologic variation. 1 Normal cutoff values vary between 200-400 ng/dL (6-13 nmol/L) depending on the assay and local laboratory reference ranges. 1
Practical Clinical Approach
- Measure early morning baseline serum 17-OHP in symptomatic individuals 1
- If baseline 17-OHP is in the intermediate range (6-300 nmol/L), proceed with cosyntropin stimulation test 1
- Obtain complete adrenocortical profile after stimulation to differentiate enzyme defects 1
- Use LC-MS/MS methodology when available rather than immunoassay 1, 5
- Consider genetic testing only when hormonal results remain equivocal 1
- Assess plasma renin activity and aldosterone to differentiate salt-wasting from simple virilizing forms in confirmed cases 1